Last edited by Fekazahn
Tuesday, July 7, 2020 | History

6 edition of Breast Cancer Management and Molecular Medicine found in the catalog.

Breast Cancer Management and Molecular Medicine

  • 296 Want to read
  • 32 Currently reading

Published by Springer .
Written in English

    Subjects:
  • Oncology,
  • Medical / Nursing,
  • Medical,
  • Gynecology & Obstetrics,
  • Radiology,
  • Biology,
  • Breast Cancer,
  • Genomics,
  • Medical / Oncology,
  • Tailoring,
  • Breast,
  • Cancer,
  • Molecular aspects

  • Edition Notes

    ContributionsMartine J. Piccart (Editor), William C. Wood (Editor), Chie-Mien Hung (Editor), Lawrence J. Solin (Editor), Fatima Cardoso (Editor)
    The Physical Object
    FormatHardcover
    Number of Pages1028
    ID Numbers
    Open LibraryOL9055825M
    ISBN 103540282653
    ISBN 109783540282655

    TY - BOOK. T1 - Molecular pathology of breast cancer. AU - Badve, Sunil. AU - Polar, Yesim. PY - /1/1. Y1 - /1/1. N2 - The complex landscape of breast cancer requires distinct strategies for the management of various molecular subtypes of this disease. This book introduces molecular imaging and Target Therapy in various cancers. This book is a useful reference for professionals engaged in nuclear medicine and clinical research, including clinical nuclear medicine physicians, nuclear medicine engineers and nuclear medicine pharmacists.

    Background. Locally advanced breast cancer is a heterogeneous disease characterized by increased local recurrence and decreased survival. It is classified into stages IIB to IIIC by the American Joint Committee on Cancer, and the prognosis of patients with this disease remains highly variable. Multimodal therapy, including chemotherapy, surgery, and radiation, is the treatment of choice. Molecular Approach to Cancer Management discusses molecular mechanisms of cancer initiation, growth and secondary spread, emphasizing how this information can be used to devise new modes of treatment of cancer, especially in combatting secondary spread. The book addresses the basic concepts relating to cancer biology, the genetic determinants, and the signal transduction cascades associated.

    Medicine; Mathematics and Statistics; Nanoscience; Physics and Astronomy; Social Sciences; Technology Transfer and Entrepreneurship; Exhibit Schedule; Health Care Industry Resources; Kudos; Media Partners; Partnering Events; Promotional Services; For Librarians. FAQs for e-prints/reprints; Journal Catalog ; Journal Catalog ; Order Bulk. Breast cancer predisposition Breast cancer diagnosis Prognostic & predictive factors in breast cancer Growth factors & receptors Conclusion & expert opinion Five-year view Key issues References Affiliations Breast cancer biomarkers and molecular medicine Jeffrey S Ross†, Gerald P Linette, James Stec, Edwin Clark, Mark Ayers.


Share this book
You might also like
Housing of social interest in Latin America and especially in Mexico.

Housing of social interest in Latin America and especially in Mexico.

Social mobility in Czechoslovakia

Social mobility in Czechoslovakia

Inalienable rights, fundamental freedoms

Inalienable rights, fundamental freedoms

The Step on the Stair

The Step on the Stair

Proceedings of the third Congress of Prehistorians of the Far East, Singapore, 24th January--30th January, 1938

Proceedings of the third Congress of Prehistorians of the Far East, Singapore, 24th January--30th January, 1938

Offset duplicator techniques.

Offset duplicator techniques.

Morning Tea - Scripture Journal

Morning Tea - Scripture Journal

Basketball Skills & Drills Book & CD Package

Basketball Skills & Drills Book & CD Package

Flight to the forest.

Flight to the forest.

Re-enactment

Re-enactment

Four sites in upland Kāneʻohe

Four sites in upland Kāneʻohe

1500 literary references everyone should know

1500 literary references everyone should know

Beckoning hills

Beckoning hills

A subalterns furlough

A subalterns furlough

Breast Cancer Management and Molecular Medicine Download PDF EPUB FB2

Contributions from experts focus on the biomedical research behind the transfer of molecular biology knowledge into the clinical management of patients. This has led to increased survival as well as improved quality of life.

The book gives an overview of the latest achievements in breast cancer and their use in clinical practice.3/5(1). This book provides an overview of the most recent techniques, agents and approaches for breast cancer that contribute to the individualization of treatment.

Current biomedical research focuses on facilitating the transfer of molecular biology knowledge into the clinical management of patients, leading to increased survival as well as improved quality of life.

The complex landscape of breast cancer requires distinct strategies for the management of various molecular subtypes of this disease. Rapid advances in the field of molecular biology have been bewildering for those involved in its study and management.

“Molecular Pathology of Breast Cancer” aims to close this knowledge gap by discussing comprehensively the evolution, biological basis and clinical applications with a focus on the “what, when, and how” of the most significant molecular. The first section of the book focuses on the molecular and genetic basis of breast cancer.

The role of specific oncogenes in mammary tumorigenesis using transgenic mice and mammary glands correlating molecular events with specific stages in neoplastic. Summary: This book gives an overview of the techniques, agents and approaches for breast cancer and the individualization of treatment.

Particular attention is given to organ-specific tailored approaches, specific populations, patients' preferences and rehabilitation.

Get this from a library. Breast cancer and molecular medicine. [Martine J Piccart-Gebhart;] -- Molecular-based medicine is taking center stage due to the increasing knowledge of breast cancer molecular biology. Treatment tailoring is no longer a dream for the future, but the main goal of.

This book provides an overview of the most recent techniques, agents and approaches for breast cancer that contribute to the individualization of treatment.

Current biomedical research focuses on facilitating the transfer of molecular biology knowledge into the clinical management of patients, leading to increased survival as well as improved quality of s: 1. Molecular testing for genetic and genomic variation has become an integral part of breast cancer management.

Patients with a family history of breast cancer or other tumors, bilateral breast cancers, or early-onset breast cancers warrant genetic testing to determine whether a hereditary cancer syndrome is present.

The availability of PARP inhibitors—drugs that are selectively active in. Molecular Pathology of Breast Cancer - Google Books The complex landscape of breast cancer requires distinct strategies for the management of various molecular subtypes of this disease.

Rapid. Breast Cancer Management welcomes unsolicited article proposals. Email us today to discuss the suitability of your research and our options for authors, including Accelerated Publication.

Find out more about publishing open access with us here. Purchase Breast Cancer - 2nd Edition. Print Book & E-Book.

ISBNThe volume provides the latest breakthroughs in breast cancer research, ranging from paradigm shifts in the surgical management of the axilla, the changing role of adjuvant and neoadjuvant chemotherapy, the impact of molecular medicine in decision-making and the.

Other types of cancer include Paget’s disease and inflammatory breast cancer. What are the Symptoms of Breast Cancer. The most common symptom of breast cancer for 90% of women is a new lump or mass in their breast.

Lumps may feel hard or soft; tender, painful or painless; irregular or rounded. Rapid advances in the field of molecular biology have been bewildering for those involved in its study and management. “Molecular Pathology of Breast Cancer” aims to close this knowledge gap by discussing comprehensively the evolution, biological basis and clinical applications with a focus on the “what, when, and how” of the most.

Now in a single convenient volume The Breast: Comprehensive Management of Benign and Malignant Diseases 5th Edition covers every clinically relevant aspect of the field: cancer congenital abnormalities hormones reconstruction anatomy and physiology benign breast disease and more.

Building upon the strengths of previous editions this updated volume by Drs. Kirby I. Bland Edward M. Copeland III. A comprehensive state-of-the-art summary of breast cancer research and treatment by leading authorities.

The book's many distinguished contributors illuminate the biology and genetics of breast cancer, including what is known about the hereditary breast cancer. Despite the fact that breast cancer mortality has moderately reduced due to currently available treatments, it is estimated that more thandeaths occur annually due to breast cancer worldwide [4,6].

Molecular subtypes of breast cancer based on histological grade and lymph node metastases, are strong prognostic and predictive factors.

Breast cancer is the most common cancer and the most frequent cause of cancer death among women worldwide. Breast cancer is a complex, heterogeneous disease classified into hormone-receptor-positive, human epidermal growth factor receptor-2 overexpressing (HER2+) and triple-negative breast cancer (TNBC) based on histological features.

Patients with untreated metastatic breast cancer demonstrate considerable heterogeneity in the clinical course of their disease. Some have a rapidly progressing tumor that metastasizes to multiple vital organs and causes death within a few months after detection of the first metastasis.

Other patients have an indolent disease course, with slow progression alternating with long periods of. Other cancer types showing FADD-containing chromosomal amplification of 11q13 region are breast cancer [25,26,27], bladder cancer [28,29,30,31], lung squamous cell carcinoma, and, less frequently, ovarian cancer, where the region commonly involved is more distal [33,34,35].

The diagnosis and management of breast cancer are undergoing a paradigm shift from a one-size-fits-all approach to an era of personalized medicine. Sophisticated diagnostics, including molecular imaging and genomic expression profiles, enable improved tumor characterization.

These diagnostics, combi .The diagnosis and management of breast cancer are undergoing a paradigm shift from a one-size-fits-all approach to an era of personalized medicine.

Sophisticated diagnostics, including molecular imaging and genomic expression profiles, enable improved tumor characterization. Impact of molecular subtype on the survival outcomes of stage IV patients. Kaplan-Meier analysis was used to determine overall survival (OS) and breast cancer-specific survival (BCSS) in the groups based on stage at the time of diagnosis (Figure S1A,B).As expected, stage IV patients exhibited worse survival rates than stage I–III patients (P.